Bizzell opioid video series

Bizzell Responds to the Opioid Crisis

Bizzell Responds to the Opioid Crisis

A Message About the Opioid Crisis

From Anton C. Bizzell, M.D.

Bizzell, President & Chief Executive Officer


[Anton C. Bizzell] The opioid crisis in
the United States, driven largely by illicitly obtained synthetic
opioids such as fentanyl, is impacting communities and
families across the country and is far from being over.
From December 1999 to June 2023,
opioid related overdose deaths increased 100 and threefold.
Hardly a day goes by when there
isn’t a news item about a family losing a loved one on illicit
fentanyl seizure. A recent fentanyl seizure by
California police of 4.2 kilos was enough to potentially kill
2.1 million people. Significant spikes in the US
overdose crisis are linked to poly substance use of synthetic
compounds such as xylazine, a veterinary tranquilizer.
Xylazine extends the duration of
action of fentanyl but does not respond to naloxone.
If an overdose occurs, it is
also associated with an increased risk of soft tissue
infections. Fentanyl impacts minorities at
an alarming rate, with overdose rates among non Hispanic blacks
suffering the highest mortality due to synthetic opioids other
than methadone. A new CDC report shows that more
black Americans died from fentanyl overdoses than any
other drug in 2021 and at a far higher rate than whites or
Hispanics. As a minority owned business,
Bizzell is committed to providing solutions to address
the current opioid crisis. At Bizzell US, all employees are
required to watch a brief training on a five step response
to an opioid overdose and are encouraged to carry naloxone
with them to stress the wide-ranging impact of the
opioid epidemic or frontline providers. Bizzell has created a
testimonial video with descriptions of the difficulties
and heart breaks of managing the opioid crisis as well as the
importance of treatment initiation in emergency
departments. An additional story about
fentanyl test strips comes from an emergency department
physician. As his daughter was heading off
to college. He taught her how to use
fentanyl test strips just in case. His foresight saved many lives
at a campus party because of this knowledge.
Bizzell US is proud to have created a variety of tools and
resources for public use in conjunction with the National
Institute on Drug Abuse Clinical Trials Network Dissemination
Initiative, bringing research based information to clinicians
on a variety of topics related to substance use disorders.
I invite you to take the time to
review all of these important resources. There is hope. With dedicated
professionals across the United States and around the world,
Bizzell is working to help turn around the opioid crisis which
effects all of us. Please join us in our efforts by
getting trained in how to recognize and manage an opioid
overdose and carry naloxone with you so you can be a first
responder. Also, please encourage anyone
you know who is using opioids to seek treatment.
Thank you.

Responding to an Overdose

This 5–step response to a possible opioid overdose, which encourages using 911 for immediate assistance and recommends that everyone carry naloxone is a quick and accessible resource.


[Maia Brown] If you come across someone with
an opiate overdose, I’d like to share with you how you can help
in five easy steps.

Step one. Check for signs of
opiate overdose. Remember that these patients
have pinpoint pupils and decreased respiratory drive,
meaning they’re breathing less than 5 times a minute or not at all. You may also see signs of drug
use on scene, like pills on the ground or an IV needle sticking
out of their arm.

Step two. Call 911 so we can
come and help you.

Step three. If you have
naloxone, go ahead and give it. You will not hurt the patient by
trying to give this medication.

Step four. Help the patient with
their breathing. If they’re not already on their
back, roll them onto their back and put them in a sniffing
position so that they have a nice open airway. Remember that naloxone can cause
patients to vomit, in which case roll them onto their side into
the recovery position.

Step 5. Continue to monitor the patient
and look for any changes in how they present to you and wait for
help to arrive. That’s all there is to it. Thank you for being willing to

Personal Testimonials

Testimonials from front line community providers stress the wide-ranging impact of the opioid crisis. Each clip describes the difficulties and heartbreaks of managing the crisis while offering hope and stressing the importance of treatment initiation in Emergency Departments.


[Ben Savitch] I worked for many years in inner
city hospitals in Chicago, and I remember distinctly one shift
many years ago where I was working in the overnight shift
and in the morning I looked up from my computer station and I
saw that our emergency department was overwhelmed with
people that were there due to opioid overdoses. Many of these individuals had
received Narcan in the field by EMS and additional doses in the
emergency department. And that was really a
recognition point for me that we were immersed in this epidemic. And certainly the issue has
persisted and extends across our entire country.

[Angadpreet “Preet” Sidhu] My community
has been disproportionately affected by the opiate crisis. Earlier this year, New York City
Health and Hygiene released their 2021 data on overdose
deaths. One particular statistic was
breakdown by neighborhood. Metropolitan Serves East Harlem,
which ranked #5 in neighborhoods with overdose deaths in all of
New York City for 100,000 residents #6 on the list was
Harlem neighborhood served by my hospital, Harlem Hospital.

[Alan Grow] They asked that any members of
the community that know of anybody struggling with
addiction to any sort of drug or alcohol, please get them help. The most important thing is
getting these people help, realizing that the stuff that
they’re doing is not only bad for them, but it’s going to harm
somebody else.

[Kavita Babu] I think it’s a real testament
to emergency medicine how much our care of patients with a opioid
use disorder has changed in my more than 20 years in practice. When I started, we would simply
give patients a handout advising them not to use drugs, but now
we’re able to send them out of our emergency departments with
things like buprenorphine, naloxone or Suboxone, meloxone
or Narcan, as well as harm reduction supplies and won’t
hand offs to treatment programs. Prescribing buprenorphine is one
of my favorite parts of my practice. Now that there’s no X waiver
required, we’re able to bring this safe and effective
treatment to our patients in a way that decreases their
mortality, all causes and opioid related by up to 50%. Getting Narcan into the right
folks hands. We know that one in seven kids
is going to be used in a reversal to save the life. Ultimately, I’m hoping that
emergency medicine can continue its trajectory towards a stigma
free environment for these patients. Patients with OUD and all of our
patients are worth saving. Thank you for being a lifesaver.

[Angadpreet “Preet” Sidhu] What needs to be
done more is to break down the stigma of medication to opiate, of
medications for opiate use disorders such as Suboxone. Narcan saves lives, but also
Suboxone saves lives as well.

Fentanyl Strips Save Lives

Dr. Edward Boyer provides a personal anecdote on how the use of fentanyl test strips saved many lives at a college campus party.


[Edward W. Boyer] Hello everyone. My name is Ed Boyer
and I have a fentanyl story. So I’m an ER doc and a medical
toxicologist. So my area of sub specialization
is overdoses, poisonings, drug interactions and that sort of
thing. I also have a certain amount of
experience and background in the drug abuse world as well. Now, my daughter was going to
college at Syracuse University and I wanted to make sure that
she went off prepared. And one of the things that I did
was I got 5 fentanyl test strips from one of our harm reduction
colleagues at Ohio State. And I gave them to her. And my message was, I’m not
condoning. I’m not expecting you to use. I don’t expect you to
experiment. But if you ever wind up in a
situation where somebody gives you something and there’s a
temptation to use it, I want you to be safe by testing it with
these test strips. She goes off to college and time
passes, and she actually does well in college. So I’m pretty confident about
how things are going. And then in April of last year,
I got a text at like 2:00 in the morning from my daughter. And it said, essentially you
saved 300 people last night. One of the fraternities had
bought some pills and they gave them around to a whole bunch of
students. And when they got back to the
dorm, some of my daughter’s friends, “friends” wanted to use
them. So they used the fentanyl test
strips. They all contain fentanyl. You know, like, I I, I don’t
know exactly how accurate it is. I don’t know what reporting
happened, you know, the Panhellenic Council heard about
it afterward. But it highlights how the easy
availability of fentanyl test strips can save lives. And it also speaks to how a
broader based public health effort is necessary to help
minimize the the impact of, you know, like adulteration of all
sorts of substances with fentanyl.

Resources and Education

Bizzell US is proud to have created a variety of tools and resources for public use in conjunction with the National Institute of Drug Abuse Clinical Trials Network Dissemination Initiative, bringing researched based information to clinicians on a variety of topics related to substance use disorders. The links provided focus on the resources created specifically to address the opioid crisis.

Reducing the Risk of Fentanyl in the U.S. Video

We can work to decrease overdose deaths by increasing awareness of the dangers of illicitly manufactured fentanyl, learning how to discuss treatment options, and demonstrating how to respond to an overdose.

NIDA CTN Slide 5

Reducing the Risk of Fentanyl in the U.S. Factsheets

Use these infographics, available in English and Spanish, to educate patients, families and communities about the dangers of illicitly manufactured fentanyl. Share the steps for recognizing and reversing overdose using naloxone.



NIDA CTN Slide 6

Overdose Prevention Education for Clinicians Treating Patients with Opioid Use Disorder Video

This brief video offers strategies for overdose prevention through identification of an individual’s risk factors, stressing the importance of treatment adherence, safety planning, and overdose rescue preparation.

NIDA CTN Slide 8

Overdose Prevention Education for Clinicians Treating Patients with Opioids for Chronic Pain

Treating patients with opioids for chronic pain includes the risk of development of opioid use disorder and overdose. This brief video offers strategies for avoiding onset of opioid use disorder as well as overdose prevention through identification of individual risk, safety planning and overdose rescue preparation.

NIDA CTN Slide 9

The Case for Buprenorphine Initiation in the Emergency Department: Why, When, and How?

Listen and learn from nationally recognized experts in these 15-minute podcasts about the importance and effectiveness of starting buprenorphine treatment for opioid use disorder (OUD) in emergency departments.

NIDA CTN Slide 11

Opioid Use Disorder in Emergency Departments

Learn best practices for patient-centered approaches to addressing opioid use disorder in the emergency department.

NIDA CTN Slide 12

Bizzell Releases Essential Opioid Overdose Response Video in Wake of National Crisis

Bizzell Releases Essential Opioid Overdose Response Video in Wake of National Crisis

January 22, 2024, New Carrollton, Maryland – As the opioid crisis continues to devastate communities with over 136 American deaths daily, primarily from fentanyl-laced drugs, Bizzell US (Bizzell) has developed and unveiled a vital educational tool. The company has released “Opioid 5 Steps to Respond to Opioid Overdose,” a video outlining critical steps to respond to an opioid overdose, developed under the guidance of leading experts in the field.

The video’s creation was informed by the extensive knowledge and experience of Bizzell’s team of specialists, including experts in health and human services, behavioral health, public health, substance use disorders, treatment and prevention, maternal and child health, medication-assisted treatment, mental health, and pharmacy operations. This collective expertise ensures that the video is not only informative but also grounded in the latest research and best practices.

Anton C. Bizzell, MD, Chairman and CEO, William H. Scarbrough, III, PhD, and Todd W. Mandell, MD are among some of notable experts at Bizzell who contributed their insights, reflecting decades of experience in fields relevant to opioid crisis management, behavioral health, and substance use disorders. Their involvement underscores Bizzell’s commitment to leveraging deep expertise in tackling this pressing public health issue.

This initiative is part of Bizzell’s broader effort to educate and empower individuals and communities in the fight against the opioid epidemic. The video is mandatory viewing for all Bizzell employees and is accompanied by a call to action to carry naloxone (Narcan), an effective emergency response medication now available over the counter.

The educational video will also be accessible on the Bizzell and the Behavioral Health Advancement Resource Center (BHARC) website, forming part of an informative mini-series on the opioid crisis.

About Bizzell US

Bizzell is a strategy, consulting, investment, & technology firm headquartered in New Carrollton, Maryland. Bizzell is a partner of choice for federal, state, and local government agencies, and private organizations. With a strong emphasis on innovation and impact, Bizzell transforms small ideas into powerful catalysts that drive change across markets worldwide. Learn more at

About Behavioral Health Advancement Resource Center (BHARC)

Bizzell established the Behavioral Health Advancement Resource Center (BHARC) to provide expert information and resources to support the behavioral health community. With BHARC, Bizzell disseminates new ideas, tools, and solutions to critical behavioral health issues including the opioid epidemic, substance use disorders, suicide prevention, and more. As a leader in behavioral health initiatives, we bring together subject matter experts with exceptional experience, as well as commitment to behavioral health solutions.

For more information, visit

Bizzell Wins Two 2023 MUSE Creative Awards for Public Health Projects

Bizzell Wins Two 2023 MUSE Creative Awards for Public Health Projects

Bizzell was awarded two 2023 MUSE Creative Awards; a Gold award for a video and Silver award for a publication, both designed to support the National Institute on Drug Abuse Clinical Trials Network Dissemination Initiative, which aims to reduce the gap that exists between the publication of research on treatment of substance use disorders and implementation in clinical practice.

This year, Bizzell received the top honor of a Gold MUSE Creative Award in the Video-Educational category for the Reducing the Risks of Fentanyl in the U.S. This video was created in collaboration with the University of Pennsylvania Center for Addiction Medicine and Policy in response to rising rates of drug overdose deaths involving opioids. The video also stresses that everyone can be a first responder by carrying naloxone.

Bizzell also won a Silver MUSE Creative Award in the Publication category for the What is Fentanyl Infographic. This infographic was produced in response to the more than 80,000 opioid overdose deaths that occurred in 2020 driven by the illegally produced fentanyl that contaminates illegally produced opioids and benzodiazepines, as well as cocaine and synthetic cannabinoids. Additional information is provided regarding the impact of fentanyl on minorities, the need for broad-reaching awareness and education about the risks of fentanyl exposure, the warning signs of a possible overdose, how to reverse an overdose, and the use of naloxone.

About The MUSE Creative Awards

The MUSE Creative Awards is part of the MUSE Awards Program, which was created by the IAA in 2015. IAA’s inception was based on a mission to honor, promote and encourage creativity by providing a new standard of excellence for evaluation media design production and distribution. IAA’s mission has largely shaped MCA’s goal.

Website: MUSE Creative Awards

Supporting Drug Prevention Week

Supporting Drug Prevention Week

By Todd W. Mandel, MD, Bizzell US

National Prevention Week is a Substance Abuse and Mental Health Services Administration (SAMHSA) led national public education campaign highlighting the work of communities and organizations dedicated to raising awareness about substance misuse prevention and positive mental health. Observed May 7–13, this week-long endeavor encourages preventative initiatives and tactics designed to increase positive mental health outcomes.

This collaborative effort helps to strengthen prevention efforts and create a culture of health and wellness, bringing together individuals, organizations, and communities across the country. Please visit the Prevention Week homepage to register and join SAMHSA in honoring of the work of their partners in prevention and celebrating stories of success.

There are numerous dangers of substance use disorders (SUDs) that can affect both an individual’s physical and mental health. SUDs can cause changes in brain chemistry that can facilitate the development of mood disorders, anxiety, and depression. SUDs contribute to potentially fatal overdoses, and other issues such as heart disease, liver and kidney damage, and respiratory issues. Additionally, SUDs can disrupt personal relationships, cause financial problems, and even lead to legal issues.

According to the CDC figures cited by the Drug Enforcement Agency (DEA), 107,375 people in the United States died of drug overdoses and drug poisonings in the 12-month period ending in January 2022 [1]United States Drug Enforcement Administration. (2022, April 29). Fentanyl Awareness. Retrieved May 9, 2023, from A staggering 67 percent of those deaths involved synthetic opioids, like fentanyl, with some of these deaths attributed to fentanyl mixed with other illicit drugs like cocaine, methamphetamine, and heroin. This illicit mixture leaves many users unaware they were taking fentanyl, further contributing to overdoses. Only two milligrams of fentanyl can be a potentially lethal dose, particularly for someone who does not have an opioid tolerance. Recent data from the DEA indicates that Fentanyl is involved in more deaths of Americans under 50 than any cause of death, including heart disease, cancer, homicide, suicide, and accident-related deaths [1]United States Drug Enforcement Administration. (2022, April 29). Fentanyl Awareness. Retrieved May 9, 2023, from

While the focus of National Prevention Week is providing an educational forum to encourage people to not start using substances, for those who are already facing challenges with SUDs, effective treatments are available. There are also other strategies and resources for overdose prevention. Bizzell US, through its work with The National Institute on Drug Abuse Clinical Trials Network, produced online educational resources on topics for screening, fentanyl overdose prevention, and treatment for methamphetamine use disorder:

Prevention efforts such as education and awareness campaigns, early intervention programs, and easy access to treatment and support are essential to reduce drug use and its harmful consequences. By working together as a community to prioritize drug use prevention, we can help individuals and families avoid the devastating effects of drug addiction, promoting a safer and healthier future for everyone.



[1] United States Drug Enforcement Administration. (2022, April 29). Fentanyl Awareness. Retrieved May 9, 2023, from